314 related articles for article (PubMed ID: 8954178)
1. Transforming growth factor-beta: a general review.
Lawrence DA
Eur Cytokine Netw; 1996 Sep; 7(3):363-74. PubMed ID: 8954178
[TBL] [Abstract][Full Text] [Related]
2. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
Chegini N
Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 3.
Cox DA
Cell Biol Int; 1995 May; 19(5):357-71. PubMed ID: 7640653
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
5. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles.
Javelaud D; Mauviel A
Int J Biochem Cell Biol; 2004 Jul; 36(7):1161-5. PubMed ID: 15109563
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce NC; Harris DL; Mello DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
[TBL] [Abstract][Full Text] [Related]
7. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
[TBL] [Abstract][Full Text] [Related]
8. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
9. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
10. Regulation and regulatory activities of transforming growth factor beta.
Bonewald LF
Crit Rev Eukaryot Gene Expr; 1999; 9(1):33-44. PubMed ID: 10200910
[TBL] [Abstract][Full Text] [Related]
11. [Transforming growth factor-betas: smad signaling and roles in physiopathology].
Javelaud D; Mauviel A
Pathol Biol (Paris); 2004 Feb; 52(1):50-4. PubMed ID: 14761714
[TBL] [Abstract][Full Text] [Related]
12. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS
Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868
[TBL] [Abstract][Full Text] [Related]
13. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix.
Tseng SC; Li DQ; Ma X
J Cell Physiol; 1999 Jun; 179(3):325-35. PubMed ID: 10228951
[TBL] [Abstract][Full Text] [Related]
14. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
15. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
Yoshizawa M; Miyazaki H; Kojima S
J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
[TBL] [Abstract][Full Text] [Related]
16. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
19. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
20. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds.
Cowin AJ; Holmes TM; Brosnan P; Ferguson MW
Eur J Dermatol; 2001; 11(5):424-31. PubMed ID: 11525949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
